Dominique Bron

Research interests

Publications

• COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus

  Leukemia · 2020 · https://doi.org/10.1038/s41375-020-0959-x

• Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma

  Annals of Oncology · 2017 · https://doi.org/10.1093/annonc/mdx289

• Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

  The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(17)31266-7

• No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial

  Journal of Clinical Oncology · 2016 · https://doi.org/10.1200/jco.2015.65.8864

• Mesenchymal stromal cells and immunomodulation: A gathering of regulatory immune cells

  Cytotherapy · 2016 · https://doi.org/10.1016/j.jcyt.2015.10.011

• High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 Trial

  Journal of Clinical Oncology · 2013 · https://doi.org/10.1200/jco.2013.51.8571

• CD4+ follicular helper T cell infiltration predicts breast cancer survival

  Journal of Clinical Investigation · 2013 · https://doi.org/10.1172/jci67428

• Relevance of a systematic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric study

  Annals of Oncology · 2013 · https://doi.org/10.1093/annonc/mds619

• Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation

  Blood · 2012 · https://doi.org/10.1182/blood-2012-08-448613

• The Germinal Center/Activated B-Cell Subclassification Has a Prognostic Impact for Response to Salvage Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Bio-CORAL Study

  Journal of Clinical Oncology · 2011 · https://doi.org/10.1200/jco.2011.35.4423

• Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, Wharton’s Jelly and bone marrow sources

  Cellular Immunology · 2010 · https://doi.org/10.1016/j.cellimm.2010.06.006

• Inflammation modifies the pattern and the function of Toll-like receptors expressed by human mesenchymal stromal cells

  Human Immunology · 2010 · https://doi.org/10.1016/j.humimm.2009.12.005

• Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6

  Cytotherapy · 2009 · https://doi.org/10.1080/14653240903079377

• microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification

  Blood · 2009 · https://doi.org/10.1182/blood-2008-11-189407

• Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP

  Annals of Hematology · 2007 · https://doi.org/10.1007/s00277-007-0399-y

• Mesenchymal Stem Cells Derived from CD133‐Positive Cells in Mobilized Peripheral Blood and Cord Blood: Proliferation, Oct4 Expression, and Plasticity

  Stem Cells · 2005 · https://doi.org/10.1634/stemcells.2004-0330

• Comparison of proposed diagnostic criteria with FACT-F and VAS for cancer-related fatigue: proposal for use as a screening tool

  Supportive Care in Cancer · 2004 · https://doi.org/10.1007/s00520-004-0734-y

• Bone marrow–derived mesenchymal stem cells already express specific neural proteins before any differentiation

  Differentiation · 2004 · https://doi.org/10.1111/j.1432-0436.2004.07207003.x

• Involved-Field Radiotherapy for Advanced Hodgkin's Lymphoma

  New England Journal of Medicine · 2003 · https://doi.org/10.1056/nejmoa022628

• Standard Chemotherapy With or Without High-Dose Chemotherapy for Aggressive Non-Hodgkin's Lymphoma: Randomized Phase III EORTC Study

  JNCI Journal of the National Cancer Institute · 2001 · https://doi.org/10.1093/jnci/93.1.22

• CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia

  Nature Medicine · 1999 · https://doi.org/10.1038/15233

• CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group.

  Journal of Clinical Oncology · 1998 · https://doi.org/10.1200/jco.1998.16.1.27

• Chronic Lymphocytic Leukemic B Cells But Not Normal B Cells Are Rescued From Apoptosis by Contact With Normal Bone Marrow Stromal Cells

  Blood · 1998 · https://doi.org/10.1182/blood.v91.7.2387

• Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response

  Blood · 1995 · https://doi.org/10.1182/blood.v86.12.4446.bloodjournal86124446

• Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma

  New England Journal of Medicine · 1995 · https://doi.org/10.1056/nejm199512073332305

• Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression.

  The Journal of Experimental Medicine · 1992 · https://doi.org/10.1084/jem.176.5.1319

Current projects

No projects listed.